Literature DB >> 15221772

Proteomic profiling of proteins decreased in hepatocellular carcinoma from patients infected with hepatitis C virus.

Yuichiro Yokoyama1, Yasuhiro Kuramitsu, Motonari Takashima, Norio Iizuka, Toshifusa Toda, Shuji Terai, Isao Sakaida, Masaaki Oka, Kazuyuki Nakamura, Kiwamu Okita.   

Abstract

Hepatocellular carcinoma (HCC) is a major cause of death in Japan. It has been suggested that hepatitis C virus (HCV) plays an important role in hepatocarcinogenesis, because of high incidence among the patients. To understand the mechanism of hepatocarcinogenesis after HCV infection, we performed a comparative study on the protein profiles between tumorous and nontumorous specimens from the patients infected with HCV by means of two-dimensional electrophoresis. Eleven spots were decreased in HCC tissues from over 50% of the patients. Eight proteins out of 11 spots were identified using peptide mass fingerprinting with matrix-assisted laser desorption/ionization-time of flight-mass spectrometry. These proteins were liver type aldolase, tropomyosin beta-chain, ketohexokinase, enoyl-CoA hydratase, albumin, smoothelin, ferritin light chain, and arginase 1. The intensity of enoyl-CoA hydratase, tropomyosin beta-chain, ketohexokinase, liver type aldolase, and arginase 1 was significantly different (p < 0.05). The decrease of 8 proteins was characteristic in HCC. We will discuss the implication of these proteins for the loss of function of hepatocytes and for the possibility of carcinogenesis of HCV-related HCC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15221772     DOI: 10.1002/pmic.200300712

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  20 in total

1.  Can proteomics lead to the discovery of real biomarkers for HCC?

Authors:  Yasuhiro Kuramitsu
Journal:  World J Hepatol       Date:  2010-02-27

2.  New multi protein patterns differentiate liver fibrosis stages and hepatocellular carcinoma in chronic hepatitis C serum samples.

Authors:  Thomas Göbel; Sonja Vorderwülbecke; Katarzyna Hauck; Holger Fey; Dieter Häussinger; Andreas Erhardt
Journal:  World J Gastroenterol       Date:  2006-12-21       Impact factor: 5.742

3.  Identification of autoantibodies to ECH1 and HNRNPA2B1 as potential biomarkers in the early detection of lung cancer.

Authors:  Liping Dai; Jitian Li; Jun-Chieh J Tsay; Ting-An Yie; John S Munger; Harvey Pass; William N Rom; Eng M Tan; Jian-Ying Zhang
Journal:  Oncoimmunology       Date:  2017-03-31       Impact factor: 8.110

4.  Capturing and identification of differentially expressed fucome by a gel free and label free approach.

Authors:  Chanida Puangpila; Ziad El Rassi
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2015-03-14       Impact factor: 3.205

5.  Contribution of laser microdissection-based technology to proteomic analysis in hepatocellular carcinoma developing on cirrhosis.

Authors:  Alexandre Dos Santos; Valérie Thiers; Sokhavuth Sar; Nicolas Derian; Noura Bensalem; Funda Yilmaz; Marie-Pierre Bralet; Béatrice Ducot; Christian Bréchot; France Demaugre
Journal:  Proteomics Clin Appl       Date:  2007-05-11       Impact factor: 3.494

6.  Proteomic analysis of chronic restraint stress-induced Gan (肝)-stagnancy syndrome in rats.

Authors:  Xue-gang Sun; Xiao-lan Zhong; Zhi-feng Liu; Hong-bing Cai; Qin Fan; Qi-rui Wang; Qiang Liu; Yu-hong Song; Song-qi He; Xu-fu Zhang; Zhi-ping Lu
Journal:  Chin J Integr Med       Date:  2010-11-26       Impact factor: 1.978

7.  Involvement of c-myc-regulated genes in hepatocellular carcinoma related to genotype-C hepatitis B virus.

Authors:  Norio Iizuka; Ryouichi Tsunedomi; Takao Tamesa; Toshimasa Okada; Kazuhiko Sakamoto; Takashi Hamaguchi; Hisafumi Yamada-Okabe; Takanobu Miyamoto; Shunji Uchimura; Yoshihiko Hamamoto; Masaaki Oka
Journal:  J Cancer Res Clin Oncol       Date:  2006-04-25       Impact factor: 4.553

8.  In-depth identification of pathways related to cisplatin-induced hepatotoxicity through an integrative method based on an informatics-assisted label-free protein quantitation and microarray gene expression approach.

Authors:  Young-Eun Cho; Thoudam S K Singh; Hyun-Chul Lee; Pyong-Gon Moon; Jeong-Eun Lee; Myung-Hoon Lee; Eung-Chil Choi; Yu-Ju Chen; Sang-Hyun Kim; Moon-Chang Baek
Journal:  Mol Cell Proteomics       Date:  2011-10-24       Impact factor: 5.911

9.  Detection of novel biomarkers of liver cirrhosis by proteomic analysis.

Authors:  Christian Mölleken; Barbara Sitek; Corinna Henkel; Gereon Poschmann; Bence Sipos; Sebastian Wiese; Bettina Warscheid; Christoph Broelsch; Markus Reiser; Scott L Friedman; Ida Tornøe; Anders Schlosser; Günter Klöppel; Wolff Schmiegel; Helmut E Meyer; Uffe Holmskov; Kai Stühler
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

10.  Proteomic differences between hepatocellular carcinoma and nontumorous liver tissue investigated by a combined gel-based and label-free quantitative proteomics study.

Authors:  Dominik A Megger; Thilo Bracht; Michael Kohl; Maike Ahrens; Wael Naboulsi; Frank Weber; Andreas-Claudius Hoffmann; Christian Stephan; Katja Kuhlmann; Martin Eisenacher; Jörg F Schlaak; Hideo A Baba; Helmut E Meyer; Barbara Sitek
Journal:  Mol Cell Proteomics       Date:  2013-03-05       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.